China vaccine maker Kovid applies for public use of shots


China-health-virus

Leading The Chinese vaccine developer has Applied for authorization to market its Covid-1 shot, trying to get a jump in the race for the inoculation race to work against the virus on Western competitors.

China National Biotech Group has sent an application to Chinese regulators, citing Xi Shengi, vice general manager of parent company Sinofarm, state media reported to Xinhua Finance. The application may contain interim data from the company’s Phase III human testing, which may have been conducted in the Middle East and South America.

Shares of Synform Group, including its Hong Kong unit, rose on Wednesday after the news broke.

A CNBG spokesman said it had no further information when contacted by Bloomberg. Synopharm group calls were unanswered.

.